Literature DB >> 30083549

The WHO-ERS Smoking Cessation Training Project: the first year of experience.

Dongbo Fu1, Christina Gratziou2,3, Carlos Jiménez-Ruiz4, Marine Faure5, Brian Ward5, Sofia Ravara6,7, Vinayak Mohan Prasad1, Kristina Mauer-Stender8, Jagdish Kaur9, Angela Ciobanu10, Syed Mahfuzul Huq11, Paraskevi Katsaounou12.   

Abstract

Strategic @ERSTalk-@WHO alliance to address tobacco use by training health professionals on brief advice resulted in establishing smoking cessation in real care settings with quit rates higher than the literature and high propensity for wider dissemination http://ow.ly/lWDF30krq5V.

Entities:  

Year:  2018        PMID: 30083549      PMCID: PMC6066529          DOI: 10.1183/23120541.00070-2018

Source DB:  PubMed          Journal:  ERJ Open Res        ISSN: 2312-0541


Globally, >7 million people die each year from tobacco use [1]. If no urgent action is taken, ≥100 million people will die from tobacco in the next 15 years [2]. Between 2010 and 2025, if tobacco use has a 50% relative reduction, it will help almost reach the global target to reduce premature noncommunicable disease (NCD) mortality by 25% by 2025 [3]. The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) Article 14 emphasises supporting current tobacco users to quit as a key component of comprehensive tobacco control strategy to avert premature NCD deaths [4, 5]. As the leading medical organisation in respiratory medicine, the European Respiratory Society (ERS) works strategically in tobacco control and strongly supports tobacco cessation, both from a policy and clinical perspective [6]. ERS created SmokeHaz [7], a website on systematic reviews of the effects of active and passive smoking on respiratory health, to provide education and disseminate the best tobacco cessation standards [8, 9]. Moreover, ERS is very active in tobacco control advocacy, led by the ERS Tobacco Control Committee, and demands a total ban on any relationship with the tobacco industry. Implementing tobacco cessation along with tobacco control measures will have synergistic effect and maximise their impact at a population level [4]. The updated Appendix 3 of the WHO Global Action Plan for Prevention and Control of NCDs 2013–2020, endorsed in May 2017 by the 70th World Health Assembly, recommends three population-wide tobacco cessation approaches (brief advice in health systems, national toll-free quit lines and mobile text messaging (mCessation)) as cost-effective NCD interventions to achieve the global NCD targets [10]. Tobacco screening and brief interventions are among the three highest-ranking clinical preventive services [11, 12]. Hence, WHO recommends establishing a comprehensive tobacco cessation and treatment system consisting of brief advice, a national toll-free quit line and mCessation, as part of any comprehensive tobacco control programme [10]. Brief advice from healthcare professionals is one of the first actions towards establishing a comprehensive tobacco cessation and treatment system in any country [4]. Training has a key role to play in promoting the delivery of all the aforementioned interventions as part of a health system strengthening approach. The WHO report on the global tobacco epidemic in 2017 [13] reveals that currently, only 35 countries provide cessation support in most of their primary care facilities and only 29 countries have cessation support in most of their hospitals. 70 countries are not providing cessation support in any of their primary care facilities and 77 countries are not providing cessation support in any of their hospitals. This situation is quite dismal. Basic training for tobacco cessation is nonexistent or poorly implemented in most countries. The incorporation of evidence-based smoking cessation into standard medical practice started in the last few decades and only few facilities have since incorporated it globally. The Global Health Professions Student Survey in 31 countries revealed that <40% of third-year students had received formal training in tobacco cessation counselling [14, 15]. Reports show that physicians do not routinely provide evidence-based tobacco cessation treatment to their patients, mainly due to lack of experience with smoking cessation techniques [16]. Inadequacy of health professionals' training in tobacco cessation is a critical health system weakness resulting in inconsistent delivery of tobacco cessation brief advice by healthcare providers as well as low availability of tobacco cessation services in many countries.

WHO–ERS collaboration on smoking cessation training

ERS already collaborates with the WHO for the full implementation of the WHO FCTC at the European, national and regional levels. Recognising the importance of tobacco cessation to attain the global NCD targets and the need for training health professionals in tobacco cessation in target countries, WHO and ERS, in 2016, formed a novel collaboration: a successive 3-year project (2016–2019) to support WHO's training activities for building capacity of WHO Member States to provide tobacco cessation interventions to all patients with respiratory diseases both in hospital and primary care settings. Three countries with high prevalence of tobacco use and low availability of tobacco cessation support were selected as target countries to implement the Year 1 project (Greece, Republic of Moldova and Bangladesh).

Year 1 project objectives, activities and achievements

WHO and ERS have successfully implemented the joint project, and achieved the two designated objectives of Year 1 between June 2016 and March 2017: 1) a national training network capable of providing further training on brief tobacco interventions for health professionals was established in each of the three target countries (figure 1); and 2) an online training course on brief tobacco interventions for health professionals was developed based on the WHO training package.
FIGURE 1

World Health Organization–European Respiratory Society Train the Trainer project first year experience in a, b) Greece (2016), c) Bangladesh (2017) and d) the Republic of Moldova (2016).

World Health Organization–European Respiratory Society Train the Trainer project first year experience in a, b) Greece (2016), c) Bangladesh (2017) and d) the Republic of Moldova (2016). Three Train the Trainer workshops were jointly conducted by WHO and ERS experts (figure 1). 30 future trainers were trained on brief tobacco intervention in each country and subsequently qualified to train primary care providers on brief tobacco interventions. Consequently, the existing training centres for on-the-job training of primary care providers were strengthened in each of the three countries to train primary care providers on brief tobacco interventions. The national training teams conducted four to six training workshops for primary care providers from two to four cities or districts in each country. All trained primary care providers were supported to deliver the “5As” and “5Rs” brief tobacco interventions from February to June 2017. >10 000 tobacco users with respiratory disease were identified and given brief advice on quitting (table 1). It is worth emphasising that the quit rates were higher than those in other studies [17].
TABLE 1

The project activities and achievements in three countries in 2016–2017

GreeceRepublic of MoldovaBangladesh
Training centres/beneficiariesHellenic Thoracic Society Aristotle University of Thessaloniki Institute of Biomedical Research of the Academy of AthensNational Centre of Public HealthState University of MedicineMinistry of Health and Family WelfareNational Tobacco Control Cell Non-communicable Disease Control Unit of Directorate General of Health Services National Institute of Cancer Research and Hospital National Institute for Preventive & Social Medicine
Activities
 Train the Trainer for national training network30 future trainers30 future trainers30 future trainers
 Primary care providers trained on brief tobacco interventions183 primary care providers in four cities120 primary care providers in four districts120 primary care providers in two districts
 Respiratory patients received brief tobacco interventions165450004000
 Patients followed upAll 1654 patients were followed up at 1 and 3 months756 out of 5000 patients were followed up at 1 month2520 out of 4000 patients were reached by phone for 1-month follow up
 Quit rate# among respiratory patients who received brief tobacco interventions613 (37.1%) quit in 1 month361 (21.8%) quit in 3 months240 (31.7%) quit in 1 month1220 (48.4%) quit in 1 month

#: 7-day point prevalence abstinence rate.

The project activities and achievements in three countries in 2016–2017 #: 7-day point prevalence abstinence rate. Moreover, a six-module online training course, “Training for primary care providers: brief tobacco interventions” (English version), has been developed to equip primary care providers with the knowledge and appropriate skills for delivering brief tobacco interventions based on the part 3 of WHO training package “Strengthening health systems for treating tobacco dependence in primary care” [18], using the Storyline software (Articulate, New York, NY, USA). The online course is accessible at http://tobacco-cessation-elearning.hk/story_html5.html. This project gained great visibility worldwide by adding the logos of ERS, WHO and concerned national authorities to all workshop materials, press/news releases issued by national authorities [19], WHO headquarters, regional and country offices [20, 21], and dissemination of the project results at several international conferences including the seventh European Conference on Tobacco or Health in 2017, the European Network for Smoking and Tobacco Prevention conference in 2017 and World Conference on Tobacco or Health in 2018.

Discussion

The WHO–ERS Smoking Cessation Training Project is a concrete example of how international cooperation is essential for building capacity of WHO Member States' health systems to promote one of the wide-reach approaches to tobacco cessation: brief tobacco interventions as part of healthcare providers' routine practice. The project and its contribution were highly appreciated by all three participating countries because it met their critical and urgent needs to strengthen their health systems to improve access to tobacco cessation services as part of their NCD prevention and control efforts. The Year 1 project results prove that this collaboration could foster sustainable infrastructure elements to promote tobacco cessation and lead to a significant impact on reducing tobacco use in the target countries. As a result of the project, a robust training network with 30 qualified trainers is available in each country. The project helped train >400 health professionals who provided brief tobacco interventions to 10 000 respiratory patients with a 1-month quit rate of >30% and 3-month rate of >20% in the three target countries. All three countries have planned follow up actions to further strengthen their national training networks and to expand training for health professionals on tobacco cessation. Greece planned to further strengthen the National Training Network in brief tobacco interventions to enhance people's access to smoking cessation interventions as part of everyday community health services; Moldova planned to expand the tobacco cessation training for primary care providers to more districts as part of WHO Package of Essential Non-communicable Disease Interventions for Primary Health Care [22] implementation; and Bangladesh planned to strengthen the tobacco cessation training network and to expand tobacco cessation service as a component of Essential Service Package in Primary Care. Despite the fact all countries had expressed strong interest and commitment to the project, the project activities under Objective 1 were implemented with a slight delay due to very tight schedules and some unavoidable events. This also undermined a longer follow-up, in order to assess 6-month tobacco cessation outcomes. The successful collaboration between WHO, ERS and other experts created a synergistic effect that is expected to spill over to neighbouring countries. The positive project results have stimulated many tobacco cessation training requests from other WHO Member States, leading to increased demand, which calls for WHO and ERS to continue and extend this project.
  10 in total

1.  Tobacco use, exposure to secondhand smoke, and cessation counseling among medical students: cross-country data from the Global Health Professions Student Survey (GHPSS), 2005-2008.

Authors:  Charles W Warren; Dhirendra N Sinha; Juliette Lee; Veronica Lea; Nathan R Jones
Journal:  BMC Public Health       Date:  2011-02-01       Impact factor: 3.295

Review 2.  Priorities among effective clinical preventive services: results of a systematic review and analysis.

Authors:  Michael V Maciosek; Ashley B Coffield; Nichol M Edwards; Thomas J Flottemesch; Michael J Goodman; Leif I Solberg
Journal:  Am J Prev Med       Date:  2006-07       Impact factor: 5.043

Review 3.  Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy.

Authors:  P Tønnesen; L Carrozzi; K O Fagerström; C Gratziou; C Jimenez-Ruiz; S Nardini; G Viegi; C Lazzaro; I A Campell; E Dagli; R West
Journal:  Eur Respir J       Date:  2007-02       Impact factor: 16.671

4.  Global Health Professions Student Survey (GHPSS) in Tobacco Control in China.

Authors:  Tingzhong Yang; Lingwei Yu; Joan L Bottorff; Dan Wu; Shuhan Jiang; Sihui Peng; Kathleen J Young
Journal:  Am J Health Behav       Date:  2015-09

5.  Implementation of World Health Organization Package of Essential Noncommunicable Disease Interventions (WHO PEN) for Primary Health Care in Low-Resource Settings: A Policy Statement From the World Hypertension League.

Authors:  Xin H Zhang; Liu Lisheng; Norm R C Campbell; Mark L Niebylski; Peter Nilsson; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-08       Impact factor: 3.738

Review 6.  Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit.

Authors:  Carlos A Jiménez-Ruiz; Stefan Andreas; Keir E Lewis; Philip Tonnesen; C P van Schayck; Peter Hajek; Serena Tonstad; Bertrand Dautzenberg; Monica Fletcher; Sarah Masefield; Pippa Powell; Thomas Hering; Stefano Nardini; Thomy Tonia; Christina Gratziou
Journal:  Eur Respir J       Date:  2015-04-16       Impact factor: 16.671

7.  Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study.

Authors:  Vasilis Kontis; Colin D Mathers; Jürgen Rehm; Gretchen A Stevens; Kevin D Shield; Ruth Bonita; Leanne M Riley; Vladimir Poznyak; Robert Beaglehole; Majid Ezzati
Journal:  Lancet       Date:  2014-05-02       Impact factor: 79.321

Review 8.  Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Authors:  O C P Van Schayck; S Williams; V Barchilon; N Baxter; M Jawad; P A Katsaounou; B J Kirenga; C Panaitescu; I G Tsiligianni; N Zwar; A Ostrem
Journal:  NPJ Prim Care Respir Med       Date:  2017-06-09       Impact factor: 2.871

9.  Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study.

Authors:  Eva Anne Marije van Eerd; Mette Bech Risør; Mark Spigt; Maciek Godycki-Cwirko; Elena Andreeva; Nick Francis; Anja Wollny; Hasse Melbye; Onno van Schayck; Daniel Kotz
Journal:  NPJ Prim Care Respir Med       Date:  2017-06-23       Impact factor: 2.871

10.  Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

  10 in total
  1 in total

Review 1.  European Respiratory Society International Congress 2018: four shades of epidemiology and tobacco control.

Authors:  Maaike de Vries; Eleanor L Axson; Jate Ratanachina; Orianne Dumas; Sara De Matteis; Annabelle Bédard; Célina Roda; Subhabrata Moitra; Elif Dagli; Athina Dimanti; Asli Gorek Dilektasli; Sofia Ravara; André F S Amaral
Journal:  ERJ Open Res       Date:  2019-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.